Literature DB >> 18696265

Polymorphisms of RANTES and IL-4 genes in cerebral infarction.

Jae-Young Um1, Hyung-Min Kim.   

Abstract

Chemoattractant peptides (chemokines) and cytokines have been shown to play a key role in the inflammatory development and progression of cerebrovascular disease. The effect of polymorphisms in regulated upon activation, normal T cells expressed, and secreted (RANTES) and interleukin-4 (IL-4) genes on cerebral infarction (CI) is evaluated in this study. Patients with CI (n = 320) and healthy controls (n = 481) were genotyped for RANTES-403 and IL-4 variable number of tandem repeat (VNTR) polymorphisms using polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism. A significant difference was observed between the CI group and controls in subjects with the RANTES AA genotype in IL-4 A3- carriers (18.6% vs. 13.1%, P = 0.035, odds ratio = 1.5, 95% confidence interval = 1.03-2.25). These findings suggest that the RANTES G-403A allele increased the relative risk for CI in the subjects without the IL-4 VNTR allele 3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18696265     DOI: 10.1007/s12031-008-9047-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  32 in total

Review 1.  Atherosclerosis. the road ahead.

Authors:  C K Glass; J L Witztum
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Chemokine RANTES promoter polymorphisms in allergic rhinitis.

Authors:  Jeong Joong Kim; Jung Hun Lee; Chul Ho Jang; Yong Shin Kim; Soo Cheon Chae; Hun Taeg Chung; Tae Wook Choi; Jae Hoon Lee
Journal:  Laryngoscope       Date:  2004-04       Impact factor: 3.325

3.  Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES.

Authors:  R G Nickel; V Casolaro; U Wahn; K Beyer; K C Barnes; B S Plunkett; L R Freidhoff; C Sengler; J R Plitt; R P Schleimer; L Caraballo; R P Naidu; P N Levett; T H Beaty; S K Huang
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

4.  Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).

Authors:  M M Le Beau; R S Lemons; R Espinosa; R A Larson; N Arai; J D Rowley
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

5.  Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1.

Authors:  Y Tanaka; Y Koyanagi; R Tanaka; Y Kumazawa; T Nishimura; N Yamamoto
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

Review 6.  The role of chemokines in atherosclerosis.

Authors:  F Mach
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

7.  Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.

Authors:  H Hendel; N Hénon; H Lebuanec; A Lachgar; H Poncelet; S Caillat-Zucman; C A Winkler; M W Smith; L Kenefic; S O'Brien; W Lu; J M Andrieu; D Zagury; F Schächter; J Rappaport; J F Zagury
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-01

8.  Genetic acceleration of AIDS progression by a promoter variant of CCR5.

Authors:  M P Martin; M Dean; M W Smith; C Winkler; B Gerrard; N L Michael; B Lee; R W Doms; J Margolick; S Buchbinder; J J Goedert; T R O'Brien; M W Hilgartner; D Vlahov; S J O'Brien; M Carrington
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

9.  Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.

Authors:  Eleonora Simeoni; Bernhard R Winkelmann; Michael M Hoffmann; Sylvain Fleury; Juan Ruiz; Lukas Kappenberger; Winfried März; Giuseppe Vassalli
Journal:  Eur Heart J       Date:  2004-08       Impact factor: 29.983

10.  The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.

Authors:  Yangsoo Jang; Jey Sook Chae; Yae Jung Hyun; Soo Jeong Koh; Ji Young Kim; Min Ji Ko; Se-Joong Rim; Hyun-Joon Shin; Jose M Ordovas; Jong Ho Lee
Journal:  Clin Sci (Lond)       Date:  2007-10       Impact factor: 6.124

View more
  4 in total

1.  Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice.

Authors:  Adám Dénes; Neil Humphreys; Thomas E Lane; Richard Grencis; Nancy Rothwell
Journal:  J Neurosci       Date:  2010-07-28       Impact factor: 6.167

2.  Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.

Authors:  Ji Hoon Phi; Naoko Suzuki; Youn Joo Moon; Ae Kyung Park; Kyu-Chang Wang; Ji Yeoun Lee; Seung-Ah Choi; Sangjoon Chong; Reizo Shirane; Seung-Ki Kim
Journal:  PLoS One       Date:  2017-01-10       Impact factor: 3.240

3.  Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.

Authors:  Hyun-Kyung Park; Myung-Chun Kim; Sung-Min Kim; Dae Jean Jo
Journal:  Exp Ther Med       Date:  2012-01-11       Impact factor: 2.447

4.  Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke.

Authors:  Dong Hwan Kim; Seung Don Yoo; Jinmann Chon; Dong Hwan Yun; Hee-Sang Kim; Hae Jeong Park; Su Kang Kim; Joo-Ho Chung; Jin Kyu Kang; Seung Ah Lee
Journal:  J Korean Med Sci       Date:  2016-02-16       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.